Anavex Life Sciences
AVXL
#7722
Rank
A$0.53 B
Marketcap
A$5.94
Share price
1.52%
Change (1 day)
-71.74%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2025 (TTM): A-$0.84

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is A-$0.80. In 2024 the company made an earnings per share (EPS) of A-$0.77 an increase over its 2023 EPS that were of A-$0.89.

EPS history for Anavex Life Sciences from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.849.45%
2024A-$0.77-13.33%
2023A-$0.89-3.23%
2022A-$0.9214.81%
2021A-$0.8020%
2020A-$0.67-16.67%
2019A-$0.8038.46%
2018A-$0.5818.18%
2017A-$0.49-21.43%
2016A-$0.62-35.38%
2015A-$0.96-36.27%
2014A-$1.51112.5%
2013A-$0.71-58.62%
2012A-$1.72-0%
2011A-$1.72-29.27%
2010A-$2.4351.85%
2009A-$1.60-0%
2008A-$1.60237.5%
2007A-$0.47
2006N/A-100%
2005A-$0.05924499.97%
2004A-$0.009874

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
A$3.54-542.59%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A-$0.07405-90.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$1.48-285.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
A-$44.28 5,437.04%๐Ÿ‡บ๐Ÿ‡ธ USA